Johnson & Johnson logo

Johnson & Johnson (JNJ)

Market Closed
14 Mar, 15:30
149. 14
-0.9
-0.6%
- Market Cap
29.06 P/E Ratio
4.96% Div Yield
0 Volume
9.91 Eps
150.04
Previous Close
Day Range
149.08 150.68
Year Range
133.24 161.06
Earnings results expected in 30 days

Summary

JNJ closed today lower at €149.14, a decrease of 0.6% from yesterday's close, completing a monthly increase of 1.37% or €2.02. Over the past 12 months, JNJ stock gained 6.38%.
JNJ pays dividends to its shareholders, with the most recent payment made on Mar 04, 2025. The next estimated payment will be in In 2 months on Jun 04, 2025 for a total of €1.24.
The last earnings report, released on Jan 22, 2025, exceeded the consensus estimates by 0.03%. On average, the company has surpassed earnings expectations by 0.08%, based on the last three reports. The next scheduled earnings report is due on Apr 14, 2025.
The stock of the company had never split.
The company's stock is traded on 18 different exchanges and in various currencies, with the primary listing on NYSE (USD).
Want to track JNJ and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!

JNJ Chart

Chart

Chart with 60 data points.
The chart has 1 X axis displaying categories.
The chart has 2 Y axes displaying values, and values.
End of interactive chart.

Johnson & Johnson Dividends

Johnson & Johnson logo
JNJ In 2 months
Estimated
Quarterly
$1.24 Per Share
Johnson & Johnson logo
JNJ 3 weeks ago
Paid
Quarterly
$1.24 Per Share
Johnson & Johnson logo
JNJ 3 months ago
Paid
Quarterly
$1.24 Per Share
Johnson & Johnson logo
JNJ 6 months ago
Paid
Quarterly
$1.24 Per Share
Johnson & Johnson logo
JNJ 9 months ago
Paid
Quarterly
$1.24 Per Share
Johnson & Johnson logo
JNJ 16 Feb 2024
Paid
Quarterly
$1.19 Per Share

Johnson & Johnson Earnings

14 Apr 2025 (30 Days) Date
-
Cons. EPS
-
EPS
22 Jan 2025 Date
2.01
Cons. EPS
2.04
EPS
21 Jan 2025 Date
-
Cons. EPS
-
EPS
15 Oct 2024 Date
2.21
Cons. EPS
2.42
EPS
17 Jul 2024 Date
2.7
Cons. EPS
2.82
EPS
Johnson & Johnson logo
JNJ In 2 months
Estimated
Quarterly
$1.24 Per Share
Johnson & Johnson logo
JNJ 3 weeks ago
Paid
Quarterly
$1.24 Per Share
Johnson & Johnson logo
JNJ 3 months ago
Paid
Quarterly
$1.24 Per Share
Johnson & Johnson logo
JNJ 6 months ago
Paid
Quarterly
$1.24 Per Share
Johnson & Johnson logo
JNJ 9 months ago
Paid
Quarterly
$1.24 Per Share
Johnson & Johnson logo
JNJ 16 Feb 2024
Paid
Quarterly
$1.19 Per Share
14 Apr 2025 (30 Days) Date
-
Cons. EPS
-
EPS
22 Jan 2025 Date
2.01
Cons. EPS
2.04
EPS
21 Jan 2025 Date
-
Cons. EPS
-
EPS
15 Oct 2024 Date
2.21
Cons. EPS
2.42
EPS
17 Jul 2024 Date
2.7
Cons. EPS
2.82
EPS

Johnson & Johnson (JNJ) FAQ

What is the stock price today?

The current price is €149.14.

On which exchange is it traded?

Johnson & Johnson is listed on NYSE.

What is its stock symbol?

The ticker symbol is JNJ.

Does it pay dividends? What is the current yield?

It does not pay dividends to its shareholders.

What is its market cap?

As of today, no market cap data is available.

What is the earnings per share?

The EPS is 0.

When is the next earnings date?

The next earnings report will release on Apr 14, 2025.

Has Johnson & Johnson ever had a stock split?

No, there has never been a stock split.

Johnson & Johnson Profile

Engineering & Construction Industry
Industrials Sector
Mr. Roberto Cecatto CEO
XWBO Exchange
US4781601046 ISIN
Italy Country
600 Employees
18 Feb 2025 Last Dividend
- Last Split
- IPO Date

Overview

Johnson & Johnson, a renowned entity in the healthcare sector, operates globally with a broad focus on research, development, manufacturing, and sales of healthcare products. The company is structured in multiple segments, primarily Innovative Medicine and MedTech, catering to a vast array of therapeutic areas and medical needs. Founded in 1886, the company is headquartered in New Brunswick, New Jersey, illustrating a longstanding presence and commitment to healthcare innovation and advancement. Through its extensive product line and diversified service offerings, Johnson & Johnson reaches a wide audience, including retailers, wholesalers, distributors, hospitals, and healthcare professionals, providing prescription and non-prescription products alike.

Products and Services

The company's portfolio is divided into two main segments, each encompassing a variety of products and services designed to meet the complex demands of modern healthcare:

  • Innovative Medicine:

    This segment includes a range of products for different therapeutic areas. These encompass immunology (covering diseases like rheumatoid arthritis, psoriatic arthritis, inflammatory bowel disease, and psoriasis), infectious diseases (including HIV/AIDS treatment), neuroscience (targeting mood disorders, neurodegenerative disorders, schizophrenia), oncology (focused on cancers such as prostate, lung, bladder, and hematologic malignancies), cardiovascular and metabolism (addressing conditions like thrombosis, diabetes, and macular degeneration), and pulmonary hypertension, specifically pulmonary arterial hypertension.

  • MedTech:

    This segment offers products and technologies across a range of medical fields. Interventional Solutions include electrophysiology products for heart rhythm disorders and technologies for severe coronary artery disease treatment. The neurovascular care line focuses on treating hemorrhagic and ischemic strokes. Orthopaedics products support treatments for hips, knees, trauma, spine, and sports injuries. The surgery portfolio covers advanced and general surgery technologies and solutions for breast aesthetics and ear, nose, and throat procedures. Additionally, MedTech offers visual health products like ACUVUE Brand contact lenses and TECNIS intraocular lenses for cataract surgery.

Contact Information

Address: Via Teulada 66
Phone: 39 06 87 16 57 50